Protalix Biotherapeutics Inc (PLX)
Depreciation & Amortization
$1.57M
TTM · Period ending: · USD
PLX Depreciation & Amortization
Latest reported$1.57Mperiod ending
Latest reported$1.57Mperiod ending
PLX TTM Depreciation & Amortization ($0.00 → $1.57M)
TTM Depreciation & Amortization
High-resolution chart · PNG
PLX depreciation & amortization history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 1,569,000 | |
| 1,523,000 | |
| 1,465,000 | |
| 1,412,000 | |
| 1,369,000 | |
| 1,328,000 | |
| 1,304,000 | |
| 1,283,000 | |
| 1,259,000 | |
| 1,233,000 | |
| 1,191,000 | |
| 1,153,000 | |
| 1,121,000 | |
| 1,096,000 | |
| 1,086,000 | |
| 1,070,000 | |
| 1,082,000 | |
| 1,102,000 | |
| 1,118,000 | |
| 1,150,000 | |
| 1,166,000 | |
| 1,212,000 | |
| 1,302,000 | |
| 1,423,000 | |
| 1,543,000 | |
| 1,588,000 | |
| 1,617,000 | |
| 1,619,000 | |
| 1,609,000 | |
| 1,646,000 | |
| 1,671,000 | |
| 1,708,000 | |
| 1,780,000 | |
| 1,858,000 | |
| 1,920,000 | |
| 1,963,000 | |
| 1,963,000 | |
| 1,959,000 | |
| 1,983,000 | |
| 2,048,000 | |
| 2,153,000 | |
| 2,270,000 | |
| 2,370,000 | |
| 2,533,000 | |
| 2,735,000 | |
| 2,928,000 | |
| 3,140,000 | |
| 3,268,000 | |
| 3,349,000 | |
| 3,441,000 | |
| 3,539,000 | |
| 3,609,000 | |
| 3,650,000 | |
| 3,688,000 | |
| 3,692,000 | |
| 3,705,000 | |
| 3,690,000 | |
| 3,683,000 | |
| 3,631,000 | |
| 3,587,000 | |
| 3,479,000 | |
| 3,314,000 | |
| 3,133,000 | |
| 2,827,000 | |
| 2,516,000 | |
| 2,232,000 | |
| 1,990,000 | |
| 1,781,000 | |
| 1,648,000 | |
| 1,494,000 | |
| 1,301,000 | |
| 1,156,000 | |
| 1,064,000 | |
| 889,000 | |
| 759,000 | |
| 1,032,000 | |
| 890,000 | |
| 850,000 | |
| 816,000 | |
| 314,000 | |
| 203,000 | |
| 98,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |